Dr. Tom Lassar, MD

NPI: 1487670048
Total Payments
$30,508
2024 Payments
$247.11
Companies
27
Transactions
185
Medicare Patients
1,211
Medicare Billing
$31,139

Payment Breakdown by Category

Other$19,650 (64.4%)
Food & Beverage$6,913 (22.7%)
Consulting$3,000 (9.8%)
Travel$854.30 (2.8%)
Gifts$75.13 (0.2%)
Education$15.39 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $11,300 5 37.0%
Honoraria $8,350 5 27.4%
Food and Beverage $6,913 159 22.7%
Consulting Fee $3,000 3 9.8%
Travel and Lodging $854.30 5 2.8%
Gift $75.13 1 0.2%
Education $15.39 7 0.1%

Top Paying Companies

Company Total Records Latest Year
Chiesi USA, Inc. $21,318 30 $0 (2023)
Janssen Scientific Affairs, LLC $2,000 1 $0 (2020)
ABIOMED $1,187 19 $0 (2020)
Medicure Pharma Inc. $1,182 4 $0 (2018)
AstraZeneca Pharmaceuticals LP $848.51 24 $0 (2021)
Boston Scientific Corporation $600.19 6 $0 (2019)
Janssen Pharmaceuticals, Inc $540.53 21 $0 (2020)
Novartis Pharmaceuticals Corporation $471.88 33 $0 (2019)
W. L. Gore & Associates, Inc. $347.20 4 $0 (2019)
Medtronic Vascular, Inc. $329.38 6 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $247.11 2 Inari Medical, Inc. ($137.39)
2023 $266.40 3 Teleflex LLC ($145.03)
2021 $617.65 4 Chiesi USA, Inc. ($575.13)
2020 $10,435 14 CHIESI USA, INC. ($8,287)
2019 $9,649 61 Chiesi USA, Inc. ($7,732)
2018 $7,474 69 Chiesi USA, Inc. ($4,628)
2017 $1,819 32 Medicure Pharma Inc. ($601.82)

All Payment Transactions

185 individual payment records from CMS Open Payments — Page 1 of 8

Date Company Product Nature Form Amount Type
12/03/2024 Edwards Lifesciences Corporation MITRIS RESILIA Mitral Valve (Device) Food and Beverage In-kind items and services $109.72 General
Category: Pericardial Heart Valves
08/20/2024 Inari Medical, Inc. FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT Food and Beverage In-kind items and services $137.39 General
Category: VTE
09/26/2023 Philips Electronics North America Corporation (6585) Omniwire (Device) Food and Beverage Cash or cash equivalent $26.23 General
Category: Medical Device
05/04/2023 Teleflex LLC GUIDELINER (Device) Food and Beverage In-kind items and services $145.03 General
Category: Interventional Access
04/27/2023 Chiesi USA, Inc. CLEVIPREX (Drug) Food and Beverage Cash or cash equivalent $95.14 General
Category: CARDIOVASCULAR
10/06/2021 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $28.95 General
05/20/2021 Chiesi USA, Inc. KENGREAL (Drug) Gift Cash or cash equivalent $75.13 General
Category: CARDIOVASCULAR
04/09/2021 Lantheus Medical Imaging, Inc. DEFINITY (Drug) Food and Beverage In-kind items and services $13.57 General
Category: CONTRAST AGENT
03/18/2021 Chiesi USA, Inc. Honoraria Cash or cash equivalent $500.00 General
12/18/2020 Janssen Scientific Affairs, LLC XARELTO (Drug) Consulting Fee Cash or cash equivalent $2,000.00 General
Category: Cardiovascular & Metabolism
10/08/2020 CHIESI USA, INC. KENGREAL (Drug) Honoraria Cash or cash equivalent $500.00 General
Category: CARDIOVASCULAR
09/10/2020 CHIESI USA, INC. KENGREAL (Drug) Honoraria Cash or cash equivalent $500.00 General
Category: CARDIOVASCULAR
02/25/2020 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $12.97 General
Category: Cardiovascular & Metabolism
02/13/2020 CHIESI USA, INC. KENGREAL (Drug) Honoraria Cash or cash equivalent $6,100.00 General
Category: CARDIOVASCULAR
02/13/2020 CHIESI USA, INC. KENGREAL (Drug) Honoraria Cash or cash equivalent $750.00 General
Category: CARDIOVASCULAR
02/13/2020 CHIESI USA, INC. KENGREAL (Drug) Travel and Lodging Cash or cash equivalent $217.84 General
Category: CARDIOVASCULAR
02/13/2020 CHIESI USA, INC. KENGREAL (Drug) Travel and Lodging Cash or cash equivalent $189.27 General
Category: CARDIOVASCULAR
02/13/2020 CHIESI USA, INC. KENGREAL (Drug) Food and Beverage Cash or cash equivalent $17.28 General
Category: CARDIOVASCULAR
02/13/2020 CHIESI USA, INC. KENGREAL (Drug) Travel and Lodging Cash or cash equivalent $13.00 General
Category: CARDIOVASCULAR
02/12/2020 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $19.31 General
Category: DIABETES
02/11/2020 ABIOMED Impella (Device) Food and Beverage In-kind items and services $87.79 General
Category: Cardiology/Vascular Diseases
01/30/2020 AstraZeneca Pharmaceuticals LP BRILINTA (Drug) Food and Beverage In-kind items and services $15.30 General
Category: Cardiovascular and Metabolism
01/14/2020 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $11.97 General
Category: DIABETES
12/18/2019 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $17.72 General
Category: CARDIOVASCULAR
12/17/2019 W. L. Gore & Associates, Inc. CARDIOFORM Septal Occluder (Device) Food and Beverage In-kind items and services $118.22 General
Category: Devices

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2021 3 501 978 $32,575 $9,822
2020 6 710 1,448 $70,780 $21,317
Total Patients
1,211
Total Services
2,426
Medicare Billing
$31,139
Procedure Codes
10

All Medicare Procedures & Services

10 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
93010 Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report Facility 2021 453 928 $20,416 $5,523 27.1%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 23 23 $8,073 $2,360 29.2%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 12 14 $1,876 $1,065 56.8%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 13 13 $2,210 $872.85 39.5%
93010 Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report Facility 2020 578 1,252 $27,544 $8,014 29.1%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 25 59 $15,694 $4,653 29.6%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 22 22 $11,352 $3,545 31.2%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 29 58 $10,730 $3,151 29.4%
99215 Established patient office or other outpatient, visit typically 40 minutes Facility 2020 17 18 $3,978 $1,525 38.3%
93018 Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report Facility 2020 39 39 $1,482 $429.84 29.0%

About Dr. Tom Lassar, MD

Dr. Tom Lassar, MD is a Cardiovascular Disease healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487670048.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tom Lassar, MD has received a total of $30,508 in payments from pharmaceutical and medical device companies, with $247.11 received in 2024. These payments were reported across 185 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($11,300).

As a Medicare-enrolled provider, Lassar has provided services to 1,211 Medicare beneficiaries, totaling 2,426 services with total Medicare billing of $31,139. Data is available for 2 years (2020–2021), covering 10 distinct procedure/service records.

Practice Information

  • Specialty Cardiovascular Disease
  • Location Cleveland, OH
  • Active Since 07/15/2006
  • Last Updated 06/29/2011
  • Taxonomy Code 207RC0000X
  • Entity Type Individual
  • NPI Number 1487670048

Products in Payments

  • KENGREAL (Drug) $20,723
  • XARELTO (Drug) $2,541
  • Impella (Device) $1,187
  • Aggrastat (tirofiban HCl) (Drug) $1,182
  • BRILINTA (Drug) $588.80
  • ENTRESTO (Drug) $471.88
  • CARDIOFORM Septal Occluder (Device) $312.59
  • Resolute (Device) $229.21
  • WATCHMAN (Device) $214.59
  • SYNERGY (Device) $174.74
  • GUIDELINER (Device) $145.03
  • FLOWTRIEVER CATHETER, S (Device) $137.39
  • VYNDAQEL (Drug) $122.76
  • IGT D Coronary (Device) $120.46
  • GENERAL - STENTS (Device) $112.56
  • MITRIS RESILIA Mitral Valve (Device) $109.72
  • Xience Sierra Coronary Stent System (Device) $104.09
  • CoreValve Evolut (Device) $100.17
  • SYNERGY BIOABSORBABLE POLYMER DRUG-ELUTING STENT SYSTEM (Device) $98.30
  • Xience V coronary stent system (Device) $96.50

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Cardiovascular Disease Doctors in Cleveland